Home » Medical Devices » UAE Cardiovascular Devices Market

UAE Cardiovascular Devices Market

UAE Cardiovascular Devices Market By Product (Diagnostic & Monitoring Devices, Surgical Devices); By End User (Hospitals & Clinics, Diagnostic Laboratories, Ambulatory Surgical Centers, Others); By Diagnostic & Monitoring Devices Type (ECG, Implantable Cardiac Monitors, Holter Monitors, Mobile Cardiac Telemetry, MRI, Others); By Surgical Devices Type (Cardiac Resynchronization Therapy (CRT), Implantable Cardioverter Defibrillators (ICDs), Pacemakers, Coronary Stents, Catheters); By Region – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2020-2023
Base Year	2024
Forecast Period	2025-2032
UAE Cardiovascular Devices Market Size 2024	USD 161.44 million
UAE Cardiovascular Devices Market, CAGR	4.7%
UAE Cardiovascular Devices Market Size 2032	USD 243.90 million

Market Overview

The UAE Cardiovascular Devices Market is projected to grow from USD 161.44 million in 2024 to an estimated USD 243.90 million by 2032, with a compound annual growth rate (CAGR) of 4.7% from 2025 to 2032. This growth is driven by the increasing prevalence of cardiovascular diseases in the country, a growing aging population, and the rising adoption of advanced medical technologies.

Several factors are driving the growth of the UAE cardiovascular devices market. These include the increasing burden of lifestyle-related diseases such as hypertension, diabetes, and obesity, which are key risk factors for heart disease. Additionally, advancements in device technology, including minimally invasive procedures, digital health solutions, and remote monitoring, are propelling the adoption of cardiovascular devices. The growing focus on healthcare infrastructure modernization and government investments in healthcare further support the market’s expansion.

Geographically, the UAE is one of the leading markets in the Middle East, with significant investments in healthcare facilities and medical technology. Key players in the UAE cardiovascular devices market include global companies such as Medtronic, Abbott Laboratories, Boston Scientific, and Siemens Healthineers. These companies are strengthening their presence in the region through partnerships, product innovations, and expanding healthcare offerings tailored to the growing demand for cardiovascular care in the UAE.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

Market Insights

The UAE Cardiovascular Devices Market is projected to grow from USD 161.44 million in 2024 to USD 243.90 million by 2032, with a CAGR of 4.7%. This growth is driven by the increasing prevalence of cardiovascular diseases and the adoption of advanced medical technologies.
The global cardiovascular devices market is projected to grow from USD 72,115.60 million in 2024 to USD 133,700.94 million by 2032, with a CAGR of 7.1% from 2025 to 2032, driven by increasing cardiovascular diseases and advancements in medical technology.
Key drivers include the rising incidence of cardiovascular diseases, lifestyle-related risk factors like hypertension and diabetes, and technological advancements in diagnostic and therapeutic devices such as minimally invasive treatments and remote monitoring.
Innovations in device technology, including AI-driven diagnostics, digital health solutions, and robotic-assisted procedures, are significantly boosting the adoption of cardiovascular devices in the UAE.
Ongoing government investments in healthcare infrastructure, modernization of medical facilities, and initiatives to improve healthcare accessibility are essential drivers for market growth.
The high cost of advanced cardiovascular devices and the lengthy approval process for new medical technologies may limit accessibility, particularly for patients with limited insurance coverage.
Dubai and Abu Dhabi dominate the UAE cardiovascular devices market due to their advanced healthcare infrastructure. Other regions, such as the northern and southern emirates, are witnessing gradual growth as healthcare facilities expand.
The UAE’s growing reputation as a medical tourism hub, particularly for cardiovascular treatments, is expected to drive the demand for high-quality cardiovascular devices, contributing to market growth.

Report Scope

This report segments the UAE Cardiovascular Devices Market as follows:

Market Drivers

Rising Prevalence of Cardiovascular Diseases

The UAE is experiencing a significant rise in the incidence of cardiovascular diseases (CVDs), driven by lifestyle factors such as poor dietary habits, lack of physical activity, and increasing rates of smoking. CVDs have become a major health concern, with cardiovascular conditions like heart disease, hypertension, and stroke affecting a large portion of the population. According to Cleveland Clinic Abu Dhabi, for instance, cardiovascular diseases account for approximately 40% of all deaths in the UAE. Additionally, studies indicate that around 50% of UAE residents have experienced heart-related conditions during their lifetime. The average age for heart attack patients in the UAE is around 10 years younger than in Western countries, highlighting the increasing burden of CVDs. This growing prevalence of CVDs is one of the primary factors driving the demand for cardiovascular devices in the region. Medical devices such as pacemakers, defibrillators, stents, and diagnostic equipment are in high demand to support early diagnosis, effective treatment, and long-term management of cardiovascular conditions. The UAE’s healthcare system is placing increasing emphasis on managing chronic diseases, including cardiovascular conditions, through advanced diagnostics and minimally invasive procedures. As a result, the market for cardiovascular devices is expanding as healthcare providers adopt the latest medical technologies to improve patient outcomes. The increasing burden of cardiovascular diseases calls for more advanced, innovative, and cost-effective cardiovascular solutions, prompting growth in both diagnostic and therapeutic devices. Furthermore, the demand for preventative measures, including wearable health monitoring devices, is growing as individuals become more aware of the risks associated with heart disease, further bolstering the market for cardiovascular devices.

Technological Advancements in Cardiovascular Devices

Technological advancements in cardiovascular devices have become one of the most significant drivers of the market in the UAE. The rapid development of high-tech diagnostic tools, minimally invasive treatment methods, and implantable devices is revolutionizing the field of cardiovascular care. Innovations such as 3D imaging for accurate diagnosis, robotic-assisted surgeries, and the use of artificial intelligence (AI) for predictive diagnostics are all playing a crucial role in transforming the landscape of cardiovascular healthcare. These advancements not only improve the accuracy of diagnosis but also lead to better treatment outcomes and faster recovery times for patients. The emergence of advanced pacemakers, stents, and defibrillators with enhanced functionalities is expanding the scope of treatment for a wide range of cardiovascular conditions. For instance, hospitals in the UAE have adopted AI-powered cardiac monitoring systems, allowing physicians to detect heart conditions with greater precision. In addition, the advent of bioabsorbable stents and catheter-based devices that require smaller incisions and offer quicker recovery times is gaining popularity in the UAE. For instance, UAE healthcare providers have implemented remote monitoring technologies for cardiac patients, improving access to continuous care and reducing hospitalization rates. With ongoing research and development in the field of cardiovascular technology, the market is expected to continue benefiting from the availability of cutting-edge products, making treatment more effective, less invasive, and more accessible to patients.

Government Initiatives and Investments in Healthcare Infrastructure

The UAE government is heavily investing in healthcare infrastructure to support the growing demand for cardiovascular care. National initiatives such as the UAE Vision 2021 and the National Health Agenda have set a clear direction for improving the healthcare system, focusing on enhancing the quality of medical services and expanding the availability of advanced healthcare technologies. The government is increasingly prioritizing healthcare as part of its economic diversification strategy, resulting in significant investments in hospitals, clinics, and medical research facilities across the country. These investments are crucial in building the infrastructure necessary to meet the rising demand for cardiovascular care and devices. Moreover, the UAE government is working to improve the overall healthcare landscape through public-private partnerships, facilitating the introduction of advanced cardiovascular technologies into the market. The country is also focusing on implementing state-of-the-art healthcare systems and building a robust regulatory framework to ensure the safety and efficacy of medical devices. As a result, the demand for cardiovascular devices continues to increase, driven by government-funded initiatives to address the growing health challenges in the region. Additionally, the government’s efforts to enhance the healthcare system have led to an increase in the number of medical professionals and specialized cardiovascular care providers, further contributing to market growth.

Growing Awareness of Heart Disease Prevention and Treatment

There has been a marked increase in public awareness of heart disease prevention and treatment in the UAE. With more individuals becoming aware of the risks associated with cardiovascular diseases, there is a growing emphasis on early detection, prevention, and management of heart-related conditions. The government and various health organizations have been conducting awareness campaigns to educate the public about the importance of healthy lifestyles, proper nutrition, and regular exercise to reduce the risk of cardiovascular diseases. These initiatives are gradually encouraging people to seek out regular check-ups and screenings, which is driving the demand for diagnostic cardiovascular devices such as blood pressure monitors, cholesterol testing equipment, and electrocardiogram (ECG) machines. In addition to government-led campaigns, private healthcare providers, pharmaceutical companies, and medical device manufacturers are also contributing to the education and awareness of cardiovascular health. The promotion of preventive measures and lifestyle changes has led to a greater demand for cardiovascular monitoring devices, including wearable health technology, that enable individuals to track their health in real-time. As more consumers adopt proactive health management practices, the market for cardiovascular devices will continue to grow, as patients increasingly seek effective tools to monitor and manage their heart health.

Market Trends

Shift Towards Minimally Invasive Procedures

There is a significant shift in the UAE cardiovascular devices market towards minimally invasive procedures, which are becoming the preferred treatment options for many cardiovascular conditions. These procedures, which use smaller incisions and involve less tissue disruption, offer several advantages including faster recovery times, reduced risk of complications, and shorter hospital stays. The increasing adoption of catheter-based treatments, such as stent implantation and balloon angioplasty, is particularly notable. For instance, hospitals in Abu Dhabi and Dubai have expanded their use of robotic-assisted catheter procedures to enhance precision and patient outcomes. Additionally, UAE healthcare facilities are investing in hybrid operating rooms that integrate real-time imaging with interventional cardiology, improving procedural accuracy and efficiency. These advancements are driven by both technological innovations and growing patient demand for less invasive treatment options. Hospitals and clinics in the UAE are increasingly investing in equipment that supports minimally invasive techniques, as these procedures not only improve patient outcomes but also reduce healthcare costs. This trend aligns with the UAE’s broader healthcare objectives, including reducing the burden on hospitals and improving the overall patient experience.

Integration of Artificial Intelligence (AI) in Diagnostics and Monitoring

Artificial intelligence (AI) is revolutionizing cardiovascular diagnostics and monitoring in the UAE. The integration of AI-driven technologies is improving the accuracy of diagnostic tools, enhancing early detection of heart diseases, and allowing for personalized treatment plans. AI algorithms are being used to analyze medical imaging, such as echocardiograms, CT scans, and MRIs, to detect anomalies with greater precision. For instance, AI-powered ECG analysis tools are now being deployed in UAE hospitals to enhance diagnostic accuracy and streamline patient management. Furthermore, AI is playing a crucial role in the development of predictive analytics tools, which help healthcare providers anticipate potential cardiovascular events in patients, allowing for more proactive management. For instance, the UAE government has implemented AI-driven healthcare initiatives to improve early detection and treatment of cardiovascular diseases in the Healthcare Sector. As the UAE healthcare sector becomes increasingly tech-driven, the use of AI in cardiovascular care is expected to rise, providing better treatment outcomes and reducing the burden on healthcare professionals.

Growth of Wearable Cardiovascular Devices

Wearable cardiovascular devices are becoming increasingly popular in the UAE as patients and healthcare providers seek continuous monitoring of heart health. These devices, such as smartwatches and fitness trackers, are equipped with advanced sensors that monitor vital parameters like heart rate, ECG, and blood oxygen levels. With the UAE’s growing focus on preventive healthcare and the increasing prevalence of chronic cardiovascular diseases, wearable devices are becoming essential tools for early detection and long-term management of heart conditions. The convenience and accessibility of these devices empower individuals to take control of their health and allow healthcare providers to monitor patients remotely. As technology advances and consumer awareness rises, the demand for wearable cardiovascular devices in the UAE is expected to continue growing, aligning with global trends in personal health management.

Rising Demand for Bioabsorbable and Next-Generation Stents

The demand for bioabsorbable stents and next-generation drug-eluting stents is increasing in the UAE as patients and healthcare providers seek more effective and longer-lasting solutions for cardiovascular interventions. Bioabsorbable stents, which gradually dissolve after performing their function, are being seen as a significant innovation as they reduce the long-term risks associated with permanent stent implantation. These stents help to prevent complications such as thrombosis and restenosis, which are common with traditional metallic stents. The UAE’s focus on offering state-of-the-art cardiovascular treatments is accelerating the adoption of these advanced stents. Additionally, the next-generation drug-eluting stents, which release medication directly to the artery, are also gaining traction due to their effectiveness in preventing the re-narrowing of arteries. These innovations are contributing to improved treatment outcomes and patient satisfaction, and as a result, the market for advanced stent technologies is expected to expand significantly in the UAE.

Market Challenges

High Cost of Advanced Cardiovascular Devices

One of the most significant challenges in the UAE cardiovascular devices market is the high cost of advanced medical technologies. Cutting-edge cardiovascular devices, such as bioabsorbable stents, advanced pacemakers, and diagnostic imaging equipment, are often expensive to procure and maintain. This cost barrier can limit their accessibility, particularly for patients with limited insurance coverage or those relying on public healthcare systems. While the UAE government has made considerable investments in healthcare infrastructure and medical technology, the affordability of these devices remains a concern. Hospitals and healthcare providers may face challenges in balancing cost containment with the need to provide state-of-the-art care to patients. Additionally, the high costs associated with these devices may also place a financial strain on healthcare providers, particularly smaller or private clinics that may not have the resources to invest in the latest equipment. For instance, the UAE has seen increased adoption of AI-powered cardiovascular diagnostic tools to enhance early detection of heart diseases, but cost barriers have slowed their widespread implementation. Although the UAE’s healthcare market is evolving, with an increasing number of private sector investments, ensuring the affordability and widespread access to advanced cardiovascular devices remains an ongoing challenge that requires strategic policy interventions and cost-effective solutions from manufacturers. In 2024, UAE-based medical technology firms introduced portable cardiac monitoring devices designed to improve patient outcomes in remote areas, yet their integration into healthcare systems has been gradual due to financial constraints.

Regulatory and Approval Delays

The regulatory environment for medical devices in the UAE, while improving, can pose significant challenges for manufacturers seeking to enter or expand in the market. The approval process for new cardiovascular devices can be lengthy and complex, requiring compliance with local health regulations and certifications. Delays in regulatory approvals can prevent manufacturers from quickly bringing new technologies to market, potentially limiting their competitive edge. Additionally, stringent quality control standards and clinical trial requirements in the UAE can prolong the time it takes for devices to be fully authorized for use. The relatively complex regulatory landscape may also create barriers for smaller companies with limited resources, thereby reducing market competition. As the market continues to grow, it is crucial for regulatory bodies to streamline approval processes and align them with international standards to encourage innovation and ensure timely availability of advanced cardiovascular devices.

Market Opportunities

Expansion of Preventive Cardiovascular Care

One of the significant market opportunities in the UAE cardiovascular devices market lies in the growing focus on preventive cardiovascular care. As awareness about the risk factors associated with cardiovascular diseases increases, there is a rising demand for diagnostic and monitoring devices that can detect potential issues at an early stage. This shift towards preventive healthcare is being supported by both public health initiatives and private healthcare investments. Devices such as portable ECG monitors, heart rate monitors, and wearable cardiovascular devices are gaining traction among consumers who are increasingly adopting healthier lifestyles. The integration of wearable health technology, such as smartwatches that monitor heart health, presents a growing opportunity for manufacturers to develop innovative solutions that allow for continuous, non-invasive monitoring. As the UAE healthcare system embraces more preventative approaches, there is a clear market opportunity for devices that support early detection, real-time monitoring, and lifestyle management, ultimately contributing to better long-term cardiovascular health outcomes.

Growth in Medical Tourism for Cardiovascular Treatments

The UAE is becoming a regional hub for medical tourism, with a growing number of patients from surrounding regions seeking high-quality cardiovascular treatments. The country’s state-of-the-art healthcare infrastructure, advanced medical technologies, and well-established healthcare providers attract international patients looking for specialized care. This influx of medical tourists seeking cardiovascular interventions presents a valuable market opportunity for device manufacturers. With an increase in elective surgeries, diagnostic procedures, and minimally invasive treatments, the demand for advanced cardiovascular devices in the UAE is expected to rise. Manufacturers can tap into this expanding market by offering innovative, cost-effective solutions tailored to the needs of international patients while capitalizing on the UAE’s reputation as a healthcare leader in the Middle East.

Market Segmentation Analysis

By Product

The UAE cardiovascular devices market can be broadly segmented into diagnostic and monitoring devices, and surgical devices. Diagnostic and monitoring devices are crucial for the early detection, assessment, and management of cardiovascular diseases. These devices include electrocardiograms (ECGs), echocardiography equipment, blood pressure monitors, and Holter monitors. As the UAE focuses on preventive healthcare and early disease detection, the demand for diagnostic and monitoring devices is increasing. These devices allow healthcare professionals to track the cardiovascular health of individuals, especially those with risk factors such as hypertension, diabetes, and obesity. Surgical devices, on the other hand, include products used in the actual treatment of cardiovascular conditions. This segment includes pacemakers, stents, defibrillators, heart valves, and surgical instruments for coronary artery bypass grafting (CABG) and other heart surgeries. The growing prevalence of heart disease, along with advancements in minimally invasive techniques, has led to increased demand for these devices. Surgical devices play a critical role in providing effective treatments for patients suffering from coronary artery disease, arrhythmias, and other heart-related issues. As healthcare in the UAE continues to advance, the surgical devices segment is expected to maintain significant growth driven by technological innovations and the increasing adoption of cutting-edge procedures.

By End-User

The UAE cardiovascular devices market can also be segmented based on end-users, with key categories including hospitals and clinics, diagnostic laboratories, ambulatory surgical centers (ASCs), and others. Hospitals and clinics represent the largest end-user segment, as they are the primary healthcare settings where cardiovascular diagnostic and treatment procedures take place. Hospitals, particularly those offering specialized cardiology services, require a wide range of cardiovascular devices for patient care, diagnosis, and surgery. The growing healthcare infrastructure in the UAE, with state-of-the-art hospitals and clinics, is a driving factor for the demand for cardiovascular devices in this segment.Diagnostic laboratories also play an essential role in the UAE cardiovascular devices market. These labs are equipped with advanced diagnostic tools to provide early detection of heart diseases through tests such as cholesterol screenings, ECGs, and blood tests. As cardiovascular diseases are becoming more prevalent, the demand for diagnostic services, including non-invasive procedures, has significantly increased. Ambulatory surgical centers (ASCs) are another growing segment, particularly due to the rise in outpatient surgeries and minimally invasive procedures. ASCs are equipped with the necessary cardiovascular devices for conducting day surgeries, such as stent placements or catheter-based interventions. This trend is expected to continue as patients increasingly seek cost-effective and convenient healthcare options.

Segments

Based on Product

Diagnostic & Monitoring Devices
Surgical Devices

Based on End User

Hospitals & Clinics
Diagnostic Laboratories
Ambulatory Surgical Centers
Others

Based on Diagnostic & Monitoring Devices Type

ECG
Implantable Cardiac Monitors
Holter Monitors
Mobile Cardiac Telemetry
MRI
Others

Based on Surgical Devices Type

Cardiac Resynchronization Therapy (CRT)
Implantable Cardioverter Defibrillators (ICDs
Pacemakers
Coronary Stents
Catheters

Based on Region

Dubai and Abu Dhabi Region
Northern Emirates
Southern Emirates and Eastern Regions

Regional Analysis

Dubai and Abu Dhabi Region (50-55%)

Dubai and Abu Dhabi represent the largest share of the UAE cardiovascular devices market, accounting for approximately 50-55% of the total market. These cities are at the forefront of healthcare advancements, with numerous world-class hospitals, specialized cardiac centers, and state-of-the-art medical facilities. The growing prevalence of cardiovascular diseases in these urban centers, coupled with the rising demand for advanced diagnostics and treatments, is driving the market in this region. Additionally, the UAE’s government initiatives to modernize healthcare facilities and encourage private sector investment in the medical industry have significantly impacted Dubai and Abu Dhabi’s dominance. The availability of high-quality cardiovascular care and a large expatriate population seeking advanced healthcare services further fuels the demand for cardiovascular devices in these cities.

Northern Emirates (20-25%)

The northern emirates, including Sharjah, Ajman, and Fujairah, contribute around 20-25% of the UAE cardiovascular devices market. While the healthcare infrastructure in these areas is developing, it is not as advanced as in Dubai and Abu Dhabi. However, the northern emirates are experiencing significant improvements in medical facilities, with increased access to specialized care and diagnostic equipment. The growing awareness of cardiovascular health, coupled with the expanding healthcare services in these regions, is expected to drive demand for cardiovascular devices. Furthermore, government investments in improving healthcare access for residents in these emirates will continue to support market growth.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key players

Abbott
GE HealthCare
Edwards Lifesciences Corporation
L. Gore & Associates, Inc.
Siemens Healthcare GmbH
BIOTRONIK SE & Co. KG
Canon Medical Systems Asia Pte. Ltd.
Cardinal Health
Medtronic
Boston Scientific Corporation
Johnson & Johnson Services, Inc.
Terumo UAE
Philips Healthcare UAE
Vasmed UAE
Life Mate Medical Equipment Trading LLC

Competitive Analysis

The UAE cardiovascular devices market is highly competitive, with a mix of global and regional players vying for market share. Leading global companies such as Abbott, Medtronic, and Boston Scientific dominate the market by offering a wide range of advanced cardiovascular products, including stents, pacemakers, and diagnostic tools. These companies leverage their extensive research and development capabilities, strong brand presence, and global expertise to maintain their leadership positions. Regional players like Terumo UAE, Philips Healthcare UAE, and Vasmed UAE are increasingly gaining traction due to their localized offerings and strong distribution networks within the UAE. Additionally, companies such as Edwards Lifesciences and Siemens Healthcare focus on innovative solutions, contributing to a competitive landscape that emphasizes technological advancements, regulatory compliance, and strategic partnerships with local healthcare providers. The market is witnessing increased collaboration between multinational and local firms, helping to meet the growing demand for high-quality cardiovascular care.

Recent Developments

In February 2025, Abbott issued a safety notification for certain Assurity and Endurity pacemakers due to potential epoxy mixing issues during manufacturing, which could lead to device malfunction.

In April 2025, GE HealthCare launched the Revolution™ Vibe CT system featuring Unlimited One-Beat Cardiac imaging and AI solutions, enhancing cardiac imaging capabilities.

In April 2025, Medtronic reported promising evidence for its Affera™ pulsed field ablation technologies in treating atrial fibrillation patients.

In May 2024, Siemens Healthineers announced new cardiology applications with artificial intelligence for the Acuson Sequoia ultrasound system, including a new 4D transesophageal (TEE) transducer for cardiology exams.

In February 2025, Philips developed a miniaturized intracardiac transducer, enabling higher-resolution views of cardiac structures and functions, benefiting structural heart disease and electrophysiology procedures.

In March 2025, Boston Scientific announced the acquisition of SoniVie Ltd. to expand its interventional cardiology therapies offerings with ultrasound-based renal denervation technology.

In June 2024, Biovac Institute entered a partnership with Sanofi to locally manufacture inactivated polio vaccines in Africa, aiming to serve the potential needs of over 40 African countries.

Market Concentration and Characteristics

The UAE cardiovascular devices market exhibits a moderately concentrated structure, dominated by both global industry leaders and emerging local players. Major multinational companies such as Abbott, Medtronic, Boston Scientific, and Philips Healthcare hold significant market share due to their advanced technological offerings, broad product portfolios, and strong distribution networks. These companies benefit from their established reputations, global research and development capabilities, and comprehensive after-sales support. In contrast, local players such as Terumo UAE and Vasmed UAE are gaining ground by tailoring their products to meet the specific needs of the UAE healthcare sector, often focusing on cost-effective solutions and localized services. The market characteristics include a growing focus on technological innovation, particularly in diagnostic devices and minimally invasive treatment solutions, as well as a high demand for quality healthcare services driven by increasing cardiovascular disease prevalence. While competition is intensifying, the market remains open to new entrants offering innovative, specialized solutions for the local healthcare environment.

Report Coverage

The research report offers an in-depth analysis based on Product, End User, Diagnostic & Monitoring Devices Type, Surgical Devices Type and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The UAE cardiovascular devices market will continue to benefit from cutting-edge technologies such as AI-driven diagnostics and robotic-assisted surgeries, improving the accuracy and efficiency of treatments.

With increasing health awareness, there will be a surge in demand for diagnostic and monitoring devices, particularly for early detection and prevention of cardiovascular diseases.

The adoption of wearable health technology, including smartwatches and fitness trackers, will expand as consumers increasingly seek ways to monitor heart health in real-time.

The demand for minimally invasive cardiovascular treatments, such as catheter-based procedures and bioabsorbable stents, will grow, driven by their benefits in reducing recovery times and complications.

The UAE government will continue to support healthcare advancements, offering incentives and funding for the development and integration of innovative cardiovascular devices into the healthcare system.

The UAE’s position as a regional healthcare hub will drive an influx of medical tourists seeking advanced cardiovascular treatments, increasing demand for state-of-the-art cardiovascular devices.

With advancements in genomics and patient-specific diagnostics, personalized cardiovascular care will become more prominent, allowing for targeted treatments and more effective device use.

The rising prevalence of lifestyle-related chronic diseases such as obesity, diabetes, and hypertension in the UAE will contribute to a higher incidence of cardiovascular diseases, boosting demand for related devices.

Continued investments in healthcare infrastructure across the UAE, including the expansion of specialized cardiovascular treatment centers, will drive the adoption of advanced cardiovascular devices in hospitals and clinics.

The growing focus on remote patient monitoring will create new opportunities for cardiovascular device manufacturers, with a rising demand for solutions that allow continuous monitoring of heart conditions outside of clinical settings.

CHAPTER NO. 1 : INTRODUCTION 17

1.1.1. Report Description 17

Purpose of the Report 17

USP & Key Product 17

1.1.2. Key Benefits for Stakeholders 17

1.1.3. Target Audience 18

1.1.4. Report Scope 18

CHAPTER NO. 2 : EXECUTIVE SUMMARY 19

2.1. Cardiovascular Devices Market Snapshot 19

2.1.1. UAE Cardiovascular Devices Market, 2018 – 2032 (USD Million) 20

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 21

3.1. Russia-Ukraine and Israel-Palestine War Impacts 21

CHAPTER NO. 4 : CARDIOVASCULAR DEVICES MARKET – INDUSTRY ANALYSIS 22

4.1. Introduction 22

4.2. Market Drivers 23

4.2.1. Driving Factor 1 Analysis 23

4.2.2. Driving Factor 2 Analysis 24

4.3. Market Restraints 25

4.3.1. Restraining Factor Analysis 25

4.4. Market Opportunities 26

4.4.1. Market Opportunities Analysis 26

4.5. Porter’s Five Force analysis 27

4.6. Value Chain Analysis 28

4.7. Buying Criteria 29

CHAPTER NO. 5 : ANALYSIS COMPETITIVE LANDSCAPE 30

5.1. Company Market Share Analysis – 2023 30

5.1.1. UAE Cardiovascular Devices Market: Company Market Share, by Revenue, 2023 30

5.1.2. UAE Cardiovascular Devices Market: Top 6 Company Market Share, by Revenue, 2023 30

5.1.3. UAE Cardiovascular Devices Market: Top 3 Company Market Share, by Revenue, 2023 31

5.2. UAE Cardiovascular Devices Market Company Revenue Market Share, 2023 32

5.3. Company Assessment Metrics, 2023 33

5.3.1. Stars 33

5.3.2. Emerging Leaders 33

5.3.3. Pervasive Players 33

5.3.4. Participants 33

5.4. Start-ups /Code Assessment Metrics, 2023 33

5.4.1. Progressive Companies 33

5.4.2. Responsive Companies 33

5.4.3. Dynamic Companies 33

5.4.4. Starting Blocks 33

5.5. Strategic Developments 34

5.5.1. Acquisition & Mergers 34

New Product Launch 34

Regional Expansion 34

5.6. Key Players Product Matrix 35

CHAPTER NO. 6 : PESTEL & ADJACENT MARKET ANALYSIS 36

6.1. PESTEL 36

6.1.1. Political Factors 36

6.1.2. Economic Factors 36

6.1.3. Social Factors 36

6.1.4. Technological Factors 36

6.1.5. Environmental Factors 36

6.1.6. Legal Factors 36

6.2. Adjacent Market Analysis 36

CHAPTER NO. 7 : CARDIOVASCULAR DEVICES MARKET – BY PRODUCT SEGMENT ANALYSIS 37

7.1. Cardiovascular Devices Market Overview, by Product Segment 37

7.1.1. Cardiovascular Devices Market Revenue Share, By Product, 2023 & 2032 38

7.1.2. Cardiovascular Devices Market Attractiveness Analysis, By Product 39

7.1.3. Incremental Revenue Growth Opportunities, by Product, 2024 – 2032 39

7.1.4. Cardiovascular Devices Market Revenue, By Product, 2018, 2023, 2027 & 2032 40

7.2. Diagnostic & Monitoring Devices 41

7.2.1. UAE Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 42

7.3. Surgical Devices 43

7.3.1. UAE Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 44

7.3.2. UAE Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 44

CHAPTER NO. 8 : CARDIOVASCULAR DEVICES MARKET – BY END USER SEGMENT ANALYSIS 45

8.1. Cardiovascular Devices Market Overview, by End User Segment 45

8.1.1. Cardiovascular Devices Market Revenue Share, By End User, 2023 & 2032 46

8.1.2. Cardiovascular Devices Market Attractiveness Analysis, By End User 47

8.1.3. Incremental Revenue Growth Opportunities, by End User, 2024 – 2032 47

8.1.4. Cardiovascular Devices Market Revenue, By End User, 2018, 2023, 2027 & 2032 48

8.2. Hospitals & Clinics 49

8.3. Diagnostic Laboratories 50

8.4. Ambulatory Surgical Centers 51

8.5. Others 52

CHAPTER NO. 9 : CARDIOVASCULAR DEVICES MARKET – UAE 53

9.1. UAE 53

9.1.1. Key Highlights 53

9.1.2. UAE Cardiovascular Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 54

9.2. Product 55

9.3. UAE Cardiovascular Devices Market Revenue, By Product, 2018 – 2023 (USD Million) 55

9.4. UAE Cardiovascular Devices Market Revenue, By Product, 2024 – 2032 (USD Million) 55

9.5. Diagnostic & Monitoring Device Types 56

9.5.1. UAE Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 56

9.5.2. UAE Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 56

9.6. Surgical Devices Types 57

9.6.1. UAE Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 57

9.6.2. UAE Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 57

9.7. End User 58

9.7.1. UAE Cardiovascular Devices Market Revenue, By End User, 2018 – 2023 (USD Million) 58

9.7.2. UAE Cardiovascular Devices Market Revenue, By End User, 2024 – 2032 (USD Million) 58

CHAPTER NO. 10 : COMPANY PROFILES 59

10.1. Abbott 59

10.1.1. Company Overview 59

10.1.2. Product Portfolio 59

10.1.3. Swot Analysis 59

10.1.4. Business Strategy 60

10.1.5. Financial Overview 60

10.2. Abbott 61

10.3. GE HealthCare 61

10.4. Edwards Lifesciences Corporation 61

10.5. W. L. Gore & Associates, Inc. 61

10.6. Siemens Healthcare GmbH 61

10.7. BIOTRONIK SE & Co. KG 61

10.8. Canon Medical Systems Asia Pte. Ltd. 61

10.9. Cardinal Health 61

10.10. Medtronic 61

10.11. Boston Scientific Corporation 61

10.12. Johnson & Johnson Services, Inc 61

10.13. Terumo UAE 61

10.14. Philips Healthcare UAE 61

10.15. Vasmed UAE 61

10.16. Life Mate Medical Equipment Trading LLC 61

10.17. Others 61

]

List of Figures

FIG NO. 1. UAE Cardiovascular Devices Market Revenue, 2018 – 2032 (USD Million) 20

FIG NO. 2. Porter’s Five Forces Analysis for UAE Cardiovascular Devices Market 27

FIG NO. 3. Value Chain Analysis for UAE Cardiovascular Devices Market 28

FIG NO. 4. Company Share Analysis, 2023 30

FIG NO. 5. Company Share Analysis, 2023 30

FIG NO. 6. Company Share Analysis, 2023 31

FIG NO. 7. Cardiovascular Devices Market – Company Revenue Market Share, 2023 32

FIG NO. 8. Cardiovascular Devices Market Revenue Share, By Product, 2023 & 2032 38

FIG NO. 9. Market Attractiveness Analysis, By Product 39

FIG NO. 10. Incremental Revenue Growth Opportunities by Product, 2024 – 2032 39

FIG NO. 11. Cardiovascular Devices Market Revenue, By Product, 2018, 2023, 2027 & 2032 40

FIG NO. 12. UAE Cardiovascular Devices Market for Diagnostic & Monitoring Devices, Revenue (USD Million) 2018 – 2032 41

FIG NO. 13. UAE Cardiovascular Devices Market for Surgical Devices, Revenue (USD Million) 2018 – 2032 43

FIG NO. 14. Cardiovascular Devices Market Revenue Share, By End User, 2023 & 2032 46

FIG NO. 15. Market Attractiveness Analysis, By End User 47

FIG NO. 16. Incremental Revenue Growth Opportunities by End User, 2024 – 2032 47

FIG NO. 17. Cardiovascular Devices Market Revenue, By End User, 2018, 2023, 2027 & 2032 48

FIG NO. 18. UAE Cardiovascular Devices Market for Hospitals & Clinics, Revenue (USD Million) 2018 – 2032 49

FIG NO. 19. UAE Cardiovascular Devices Market for Diagnostic Laboratories, Revenue (USD Million) 2018 – 2032 50

FIG NO. 20. UAE Cardiovascular Devices Market for Ambulatory Surgical Centers, Revenue (USD Million) 2018 – 2032 51

FIG NO. 21. UAE Cardiovascular Devices Market for Others, Revenue (USD Million) 2018 – 2032 52

FIG NO. 22. UAE Cardiovascular Devices Market Revenue, 2018 – 2032 (USD Million) 53

List of Tables

TABLE NO. 1. : UAE Cardiovascular Devices Market: Snapshot 19

TABLE NO. 2. : Drivers for the Cardiovascular Devices Market: Impact Analysis 23

TABLE NO. 3. : Restraints for the Cardiovascular Devices Market: Impact Analysis 25

TABLE NO. 4. : UAE Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 42

TABLE NO. 5. : UAE Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 42

TABLE NO. 6. : UAE Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 44

TABLE NO. 7. : UAE Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 44

TABLE NO. 8. : UAE Cardiovascular Devices Market Revenue, By Country, 2018 – 2023 (USD Million) 54

TABLE NO. 9. : UAE Cardiovascular Devices Market Revenue, By Country, 2024 – 2032 (USD Million) 54

TABLE NO. 10. : UAE Cardiovascular Devices Market Revenue, By Product, 2018 – 2023 (USD Million) 55

TABLE NO. 11. : UAE Cardiovascular Devices Market Revenue, By Product, 2024 – 2032 (USD Million) 55

TABLE NO. 12. : UAE Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 56

TABLE NO. 13. : UAE Cardiovascular Devices Market Revenue, By Diagnostic & Monitoring Device Types, 2018 – 2023 (USD Million) 56

TABLE NO. 14. : UAE Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 57

TABLE NO. 15. : UAE Cardiovascular Devices Market Revenue, By Surgical Devices Types, 2018 – 2023 (USD Million) 57

TABLE NO. 16. : UAE Cardiovascular Devices Market Revenue, By End User, 2018 – 2023 (USD Million) 58

TABLE NO. 17. : UAE Cardiovascular Devices Market Revenue, By End User, 2024 – 2032 (USD Million) 58

Frequently Asked Questions

What is the projected market size of the UAE Cardiovascular Devices Market in 2024 and 2032?

The UAE Cardiovascular Devices Market is projected to grow from USD 161.44 million in 2024 to an estimated USD 243.90 million by 2032, reflecting significant growth over the forecast period.

What is the expected compound annual growth rate (CAGR) of the UAE Cardiovascular Devices Market?

The market is expected to grow at a compound annual growth rate (CAGR) of 4.7% from 2025 to 2032, driven by advancements in medical technologies and increasing cardiovascular disease prevalence.

Which companies are leading the UAE cardiovascular devices market?

Leading global companies such as Medtronic, Abbott Laboratories, Boston Scientific, and Siemens Healthineers are key players in the UAE cardiovascular devices market, contributing to innovation and expansion.

How does the growing aging population impact the UAE Cardiovascular Devices Market?

The growing aging population in the UAE is contributing to the rise in cardiovascular diseases, driving the demand for advanced diagnostic and therapeutic cardiovascular devices across the region.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$8699

Let us help you

WILLIAM, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

LEE VALLANCE, Asia Pacific

+64 22 017 0275

EMAIL US

Request Sample

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –